Clinical Study of ARD103 CAR-T Therapy for Patients with R/R AML or MDS

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase I/2, interventional, open-label, multicenter study to assess the safety and efficacy of ARD103 in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndrome.
Epistemonikos ID: b7ec48a804f0e21c07b6dc7df97461e54fc1da16
First added on: Dec 01, 2024